Prospective quality-of-life outcomes for low-risk prostate cancer: Active surveillance versus radical prostatectomy

Cancer

Volumn 121, Issue 14, 2015, Pages 2465-2473

  Jeldres, Claudio ^a,b   Cullen, Jennifer ^c,d,e   Hurwitz, Lauren M ^c,d   Wolff, Erika M ^a   Levie, Katherine E ^c,d   Odem Davis, Katherine ^f   Johnston, Richard B ^a   Pham, Khanh N ^a   Rosner, Inger L ^c,g   Brand, Timothy C ^c,h   L'Esperance, James O ^c,i   Sterbis, Joseph R ^c,j   Etzioni, Ruth ^k   Porter, Christopher R ^a,c  

^a Sect of Urol and Ren Transplant   (United States)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Center for Prostate Disease Research   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^e Uniformed Services University of the Health Sciences   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g WALTER REED ARMY MEDICAL CENTER   (United States)

^h MADIGAN ARMY MEDICAL CENTER   (United States)

ⁱ NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^j TRIPLER ARMY MEDICAL CENTER   (United States)

^k Fred Hutchinson Cancer Research Center   (United States)

more..

Author keywords

active surveillance; prostate cancer; quality of life; radical prostatectomy; survivorship

Indexed keywords

AGED; HEALTH STATUS; HEALTH SURVEY; HUMAN; MALE; MENTAL HEALTH; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRE; WATCHFUL WAITING;

AGED; HEALTH STATUS; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; WATCHFUL WAITING;

EID: 84934438945     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29370     Document Type: Article

References (33)

1. Cooperberg MR, Lubeck DP, Meng MV, Mehta SS, Carroll PR,. The changing face of low-risk prostate cancer: trends in clinical presentation and primary management. J Clin Oncol. 2004; 22: 2141-2149.
2. Aizer AA, Paly JJ, Zietman AL, et al., Models of care and NCCN guideline adherence in very-low-risk prostate cancer. J Natl Compr Canc Netw. 2013; 11: 1364-1372.
3. Klotz L, Zhang L, Lam A, Nam R, Mamedov A, Loblaw A,. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010; 28: 126-131.
4. Wright JL, Lin DW, Cowan JE, Carroll PR, Litwin MS, Ca PI,. Quality of life in young men after radical prostatectomy. Prostate Cancer Prostatic Dis. 2008; 11: 67-73.
5. Wilcox CB, Gilbourd D, Louie-Johnsun M,. Anxiety and health-related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int. 2014; 113: 64-68.
6. Penson DF, McLerran D, Feng Z, et al., 5-year urinary and sexual outcomes after radical prostatectomy: results from the Prostate Cancer Outcomes Study. J Urol. 2005; 173: 1701-1705.
7. Resnick MJ, Koyama T, Fan KH, et al., Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med. 2013; 368: 436-445.
8. Sanda MG, Dunn RL, Michalski J, et al., Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008; 358: 1250-1261.
9. Hayes JH, Ollendorf DA, Pearson SD, et al., Active surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis. JAMA. 2010; 304: 2373-2380.
10. Johansson E, Steineck G, Holmberg L, et al., Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trial. Lancet Oncol. 2011; 12: 891-899.
11. Brassell SA, Dobi A, Petrovics G, Srivastava S, McLeod D,. The Center for Prostate Disease Research (CPDR): a multidisciplinary approach to translational research. Urol Oncol. 2009; 27: 562-569.
12. Wei JT, Dunn RL, Litwin MS, Sandler HM, Sanda MG,. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000; 56: 899-905.
13. Ware JE Jr,. SF-36 health survey update. Spine (Phila Pa). 2000; 25: 3130-3139.
14. Brazier JE, Harper R, Jones NM, et al., Validating the SF-36 health survey questionnaire: new outcome measure for primary care [serial online]. BMJ. 1992; 305: 160-164.
15. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. V3.2012. Fort Washington, PA: NCCN; 2012.
16. Zeger SL, Liang KY, Albert PS,. Models for longitudinal data: a generalized estimating equation approach. Biometrics. 1988; 44: 1049-1060.
17. Norman GR, Sloan JA, Wyrwich KW,. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003; 41: 582-592.
18. Filson CP, Schroeck FR, Ye Z, Wei JT, Hollenbeck BK, Miller DC,. Variation in use of active surveillance among men undergoing expectant treatment for early stage prostate cancer. J Urol. 2014; 192: 75-80.
19. Kim SP, Gross CP, Nguyen PL, et al., Perceptions of active surveillance and treatment recommendations for low-risk prostate cancer: results from a National Survey of radiation oncologists and urologists. Med Care. 2014; 52: 579-585.
20. Bergman J, Litwin MS,. Quality of life in men undergoing active surveillance for localized prostate cancer. J Natl Cancer Inst Monogr. 2012;2012: 242-249.
21. Steineck G, Helgesen F, Adolfsson J, et al., Quality of life after radical prostatectomy or watchful waiting. N Engl J Med. 2002; 347: 790-796.
22. Siston AK, Knight SJ, Slimack NP, et al., Quality of life after a diagnosis of prostate cancer among men of lower socioeconomic status: results from the Veterans Affairs Cancer of the Prostate Outcomes Study. Urology. 2003; 61: 172-178.
23. Punnen S, Cowan JE, Chan JM, Carroll PR, Cooperberg MR,. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry [published online ahead of print September 18, 2014]. Eur Urol. 2014.
24. Smith DP, King MT, Egger S, et al., Quality of life 3 years after diagnosis of localised prostate cancer: population based cohort study [serial online]. BMJ. 2009; 339: b4817.
25. Mols F, van de Poll-Franse LV, Vingerhoets AJ, et al., Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer. 2006; 107: 2186-2196.
26. Venderbos LD, van den Bergh RC, Roobol MJ, et al., A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels. Psychooncology. 2015; 24: 348-354.
27. Vasarainen H, Lokman U, Ruutu M, Taari K, Rannikko A,. Prostate cancer active surveillance and health-related quality of life: results of the Finnish arm of the prospective trial. BJU Int. 2012; 109: 1614-1619.
28. Aizer AA, Paly JJ, Efstathiou JA,. Multidisciplinary care and management selection in prostate cancer. Semin Radiat Oncol. 2013; 23: 157-164.
29. van den Bergh RC, de Blok W, van Muilekom E, Tillier C, Venderbos LD, van der Poel HG,. Impact on quality of life of radical prostatectomy after initial active surveillance: more to lose? Scand J Urol. 2014; 48: 367-373.
30. Crook JM, Gomez-Iturriaga A, Wallace K, et al., Comparison of health-related quality of life 5 years after SPIRIT: Surgical Prostatectomy Versus Interstitial Radiation Intervention Trial. J Clin Oncol. 2011; 29: 362-368.
31. Lane JA, Donovan JL, Davis M, et al., Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial. Lancet Oncol. 2014; 15: 1109-1118.
32. Daubenmier JJ, Weidner G, Marlin R, et al., Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006; 67: 125-130.
33. Wang X, Wang X, Liu T, He Q, Wang Y, Zhang X,. Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy [serial online]. PLoS One. 2014; 9: e91327.